Cargando...
Cost Effectiveness of DCISionRT for Guiding Treatment of Ductal Carcinoma in Situ
The DCISionRT test estimates the risk of an ipsilateral breast event (IBE) in patients with ductal carcinoma in situ (DCIS) as well as the benefit of adjuvant radiation therapy (RT). We determined the cost-effectiveness of DCISionRT using a Markov model simulating 10-year outcomes for 60-year-old wo...
Guardado en:
| Publicado en: | JNCI Cancer Spectr |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Oxford University Press
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7083239/ https://ncbi.nlm.nih.gov/pubmed/32211582 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jncics/pkaa004 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|